Premium
Sutro Biopharma Inc (STRO)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Mr. Gregory K. ChowCFO | 2,50k | 0,00 | Derivative Exercise and Retained Stock | - | 4,73k | 112,36% |
| 2026-03-04 | Mr. David PaulingChief Administrative Officer & General Counsel | 398,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,75k | 4,26% |
| 2026-03-04 | Mr. David PaulingChief Administrative Officer & General Counsel | -277,00 | 5,90k | Derivative Exercise and Sale | 21,31 | 9,75k | - |
| 2026-03-04 | Ms. Jane ChungCEO & Director | 506,00 | 0,00 | Derivative Exercise and Retained Stock | - | 21,29k | 2,44% |
| 2026-03-04 | Ms. Jane ChungCEO & Director | -282,00 | 6,01k | Derivative Exercise and Sale | 21,31 | 21,29k | - |
| 2026-03-01 | Mr. David PaulingChief Administrative Officer & General Counsel | 2,18k | 0,00 | Derivative Exercise and Retained Stock | - | 9,35k | 30,35% |
| 2026-03-01 | Mr. David PaulingChief Administrative Officer & General Counsel | -1,52k | 31,21k | Derivative Exercise and Sale | 20,47 - 20,55 | 9,35k | - |
| 2026-03-01 | Dr. Hans-Peter GerberChief Scientific Officer | 2,34k | 0,00 | Derivative Exercise and Retained Stock | - | 9,52k | 32,51% |
| 2026-03-01 | Dr. Hans-Peter GerberChief Scientific Officer | -1,63k | 33,52k | Derivative Exercise and Sale | 20,47 - 20,55 | 9,52k | - |
| 2026-03-01 | Ms. Jane ChungCEO & Director | 6,89k | 0,00 | Derivative Exercise and Retained Stock | - | 20,78k | 49,59% |
| 2026-03-01 | Ms. Jane ChungCEO & Director | -4,05k | 83,13k | Derivative Exercise and Sale | 20,47 - 20,55 | 20,78k | - |
| 2025-12-12 | Ms. Jane ChungCEO & Director | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 13,89k | 13,07% |
| 2025-12-12 | Ms. Jane ChungCEO & Director | -894,00 | 7,17k | Derivative Exercise and Sale | 8,02 | 13,89k | - |
| 2025-10-15 | Dr. Hans-Peter GerberChief Scientific Officer | 1,70k | 13,61k | Achat | 8,00 | 7,18k | 31,00% |
| 2025-10-15 | Mr. Gregory K. ChowCFO | 1,98k | 16,00k | Achat | 8,10 | 1,98k | - |
| 2025-10-15 | Ms. Jane ChungCEO & Director | 1,25k | 10,01k | Achat | 8,01 | 12,29k | 11,33% |
| 2025-10-15 | Ms. Connie L. MatsuiIndependent Chair of the Board | 5,00k | 39,95k | Achat | 7,99 | 5,00k | - |
| 2025-10-15 | Mr. David PaulingChief Administrative Officer & General Counsel | 1,25k | 9,99k | Achat | 7,99 | 7,17k | 21,11% |
| 2025-09-18 | Dr. Hans-Peter GerberChief Scientific Officer | 2,41k | 0,00 | Derivative Exercise and Retained Stock | - | 5,48k | 78,33% |
| 2025-09-18 | Dr. Hans-Peter GerberChief Scientific Officer | -1,34k | 12,08k | Derivative Exercise and Sale | 9,00 | 5,48k | - |
| 2025-08-09 | Ms. Jane ChungCEO & Director | 1,20k | 0,00 | Derivative Exercise and Retained Stock | - | 11,04k | 12,25% |
| 2025-08-09 | Ms. Jane ChungCEO & Director | -670,80 | 5,37k | Derivative Exercise and Sale | 8,00 | 11,04k | - |
| 2025-07-08 | Dr. Barbara LeymanInitié | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 1,61k | - |
| 2025-07-08 | Dr. Barbara LeymanInitié | -894,40 | 6,98k | Derivative Exercise and Sale | 7,80 | 1,61k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
